| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Beam Therapeutics Inc (NASDAQ: BEAM)
BEAM Technical Analysis
5
| As on 9th Jun 2023 BEAM STOCK Price closed @ 32.21 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 54.65 & Strong Sell for SHORT-TERM with Stoploss of 70.98 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BEAMSTOCK Price
| Open | 34.00 | Change | Price | % |
| High | 34.00 | 1 Day | -1.24 | -3.71 |
| Low | 31.94 | 1 Week | 0.31 | 0.97 |
| Close | 32.21 | 1 Month | 1.71 | 5.61 |
| Volume | 738172 | 1 Year | -42.68 | -56.99 |
| 52 Week High 86.50 | 52 Week Low 29.32 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| BEAM Daily Charts |
BEAM Intraday Charts |
Whats New @ Bazaartrend |
BEAM Free Analysis |
|
|
BEAM Important Levels Intraday
| RESISTANCE | 36.18 |
| RESISTANCE | 34.91 |
| RESISTANCE | 34.12 |
| RESISTANCE | 33.33 |
| SUPPORT | 31.09 |
| SUPPORT | 30.30 |
| SUPPORT | 29.51 |
| SUPPORT | 28.24 |
BEAM Forecast May 2024
| 4th UP Forecast | 82.39 |
| 3rd UP Forecast | 66.3 |
| 2nd UP Forecast | 56.35 |
| 1st UP Forecast | 46.4 |
| 1st DOWN Forecast | 18.02 |
| 2nd DOWN Forecast | 8.07 |
| 3rd DOWN Forecast | -1.88 |
| 4th DOWN Forecast | -17.97 |
BEAM Weekly Forecast
| 4th UP Forecast | 52.75 |
| 3rd UP Forecast | 46.16 |
| 2nd UP Forecast | 42.09 |
| 1st UP Forecast | 38.02 |
| 1st DOWN Forecast | 26.40 |
| 2nd DOWN Forecast | 22.33 |
| 3rd DOWN Forecast | 18.26 |
| 4th DOWN Forecast | 11.67 |
BEAM Forecast2024
| 4th UP Forecast | 148.62 |
| 3rd UP Forecast | 111.29 |
| 2nd UP Forecast | 88.21 |
| 1st UP Forecast | 65.13 |
| 1st DOWN Forecast | -0.71 |
| 2nd DOWN Forecast | -23.79 |
| 3rd DOWN Forecast | -46.87 |
| 4th DOWN Forecast | -84.2 |
Beam Therapeutics Inc ( NASDAQ USA Symbol : BEAM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
BEAM Business Profile
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts. Address: 26 Landsdowne Street, Cambridge, MA, United States, 02139
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service